Vaginal microbiome and sexually transmitted infections: An epidemiologic perspective

Journal of Clinical Investigation

Volumn 121, Issue 12, 2011, Pages 4610-4617

  Brotman, Rebecca M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DNA 16S; LACTIC ACID; METRONIDAZOLE;

ANAEROBIC BACTERIUM; CHLAMYDIA; CONDOM; DNA DETERMINATION; GONORRHEA; GRAM STAINING; HERPES SIMPLEX; HUMAN; LACTOBACILLUS; MENSTRUATION; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; NONHUMAN; ORAL SEXUAL CONTACT; PELVIC INFLAMMATORY DISEASE; POLYMERASE CHAIN REACTION; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; ULCUS MOLLE; VAGINA FLORA; VAGINA SECRETION; VAGINA SMEAR; VAGINAL LAVAGE; VAGINITIS;

BACTERIA, ANAEROBIC; DISEASE SUSCEPTIBILITY; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; LACTOBACILLUS; METAGENOME; MICROBIAL INTERACTIONS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RIBOTYPING; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; VAGINA; VAGINAL SMEARS; VAGINOSIS, BACTERIAL;

EID: 84055193937     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI57172     Document Type: Review

References (112)

1. Hillier SL, Holmes KK, Marrazzo JM. Bacterial vaginosis. In: Holmes K, et al. Sexually Transmitted Diseases. New York New York, USA: McGraw-Hill, Health Professions Division; 2008:737-768.
2. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74(1):14-22. (Pubitemid 13221599)
3. Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis. 2003;36(5):663-668. (Pubitemid 36259574)
4. Peters SE, et al. Behaviors associated with Neisseria gonorrhoeae and Chlamydia trachomatis: cervical infection among young women attending adolescent clinics. Clin Pediatr (Phila). 2000;39(3):173-177. (Pubitemid 30161273)
5. Martin HL, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis. 1999;180(6):1863-1868.
6. Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis. 2003;37(3):319-325. (Pubitemid 36976487)
7. Cu-Uvin S, et al. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis. 2001;33(6):894-896. (Pubitemid 32831848)
8. Taha TE, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 1998;12(13):1699-1706. (Pubitemid 28418342)
9. Schwebke JR. Gynecologic consequences of bacterial vaginosis. Obstet Gynecol Clin North Am. 2003; 30(4):685-694. (Pubitemid 38018632)
10. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008;22(12):1493-1501.
11. Ness RB, et al. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol. 2005;162(6):585-590. (Pubitemid 41253257)
12. Cohn JA, et al. HIV-inducing factor in cervicovaginal secretions is associated with bacterial vaginosis in HIV-1-infected women. J Acquir Immune Defic Syndr. 2005;39(3):340-346. (Pubitemid 40923216)
13. Sha BE, et al. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis. 2005;191(1):25-32. (Pubitemid 40041396)
14. Coleman JS, et al. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS. 2007;21(6):755-759. (Pubitemid 46568633)
15. Cherpes TL, Melan MA, Kant JA, Cosentino LA, Meyn LA, Hillier SL. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis. 2005;40(10):1422-1428. (Pubitemid 40628629)
16. Oakeshott P, Hay P, Hay S, Steinke F, Rink E, Kerry S. Association between bacterial vaginosis or chlamydial infection and miscarriage before 16 weeks'gestation: prospective community based cohort study. BMJ. 2002;325(7376):1334.
17. Donders GG, Van Bulck B, Caudron J, Londers L, Vereecken A, Spitz B. Relationship of bacterial vaginosis and mycoplasmas to the risk of spontaneous abortion. Am J Obstet Gynecol. 2000;183(2):431-437. (Pubitemid 30651093)
18. Llahi-Camp JM, Rai R, Ison C, Regan L, Taylor-Robinson D. Association of bacterial vaginosis with a history of second trimester miscarriage. Hum Reprod. 1996;11(7):1575-1578. (Pubitemid 26335116)
19. Nelson DB, Bellamy S, Nachamkin I, Ness RB, Macones GA, Allen-Taylor L. First trimester bacterial vaginosis, individual microorganism levels, and risk of second trimester pregnancy loss among urban women. Fertil Steril. 2007;88(5):1396-1403. (Pubitemid 350047493)
20. Nelson DB, et al. Preterm labor and bacterial vaginosis- associated bacteria among urban women. J Perinat Med. 2009;37(2):130-134.
21. Hillier SL, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med. 1995;333(26):1737-1742.
22. Meis PJ, et al. The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 1995;173(4):1231- 1235.
23. Nygren P, et al. Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;148(3):220-233. (Pubitemid 351665509)
24. Klebanoff MA, Schwebke JR, Zhang J, Nansel TR, Yu KF, Andrews WW. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol. 2004;104(2):267-272. (Pubitemid 40458871)
25. Hugenholtz P, Goebel BM, Pace NR. Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J Bacteriol. 1998;180(18):4765-4774. (Pubitemid 28429361)
26. Ronaghi M. Pyrosequencing sheds light on DNA sequencing. Genome Res. 2001;11(1):3-11. (Pubitemid 32117949)
27. Margulies M, et al. Genome sequencing in micro-fabricated high-density picolitre reactors. Nature. 2005;437(7057):376-380. (Pubitemid 41613494)
28. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005;353(18):1899- 1911. (Pubitemid 41565955)
29. Ferris MJ, Masztal A, Aldridge KE, Fortenberry JD, FidelPL Jr, Martin DH. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis. 2004;4:5.
30. Ravel J, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011; 108 suppl 1:4680-4687.
31. Sobel JD, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol. 2006;194(5):1283-1289.
32. Bradshaw CS, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006;193(11):1478-1486. (Pubitemid 43794575)
33. Swidsinski A, et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 2008;198(1):97-6.
34. Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010;59(RR-12):1-110.
35. Spiegel CA, Amsel R, Holmes KK. Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol. 1983;18(1):170-177. (Pubitemid 13056830)
36. Ison CA, Hay PE. Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm Infect. 2002;78(6):413-415. (Pubitemid 36020813)
37. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29(2):297-301.
38. Joesoef MR, Hillier SL, Josodiwondo S, Linnan M. Reproducibility of a scoring system for gram stain diagnosis of bacterial vaginosis. J Clin Microbiol. 1991; 29(8):1730-1731.
39. Schwebke JR, Hillier SL, Sobel JD, McGregor JA, Sweet RL. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol. 1996;88(4 pt 1):573-576. (Pubitemid 26326021)
40. Koumans EH, et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis. 2007;34(11):864-869. (Pubitemid 350287499)
41. Morgan DJ, Aboud CJ, McCaffrey IM, Bhide SA, Lamont RF, Taylor-Robinson D. Comparison of Gram-stained smears prepared from blind vaginal swabs with those obtained at speculum examination for the assessment of vaginal flora. Br J Obstet Gynaecol. 1996;103(11):1105-1108. (Pubitemid 26371057)
42. Brotman RM, Ghanem KG, Klebanoff MA, Taha TE, Scharfstein DO, Zenilman JM. The effect of vaginal douching cessation on bacterial vaginosis: a pilot study. Am J Obstet Gynecol. 2008;198(6):628-7.
43. Schwebke JR, Morgan SC, Weiss HL. The use of sequential self-obtained vaginal smears for detecting changes in the vaginal flora. Sex Transm Dis. 1997; 24(4):236-239. (Pubitemid 27155106)
44. Brotman RM, Erbelding EJ, Jamshidi RM, Klebanoff MA, Zenilman JM, Ghanem KG. Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics. J Pediatr Adolesc Gynecol. 2007; 20(4):225-231. (Pubitemid 47126329)
45. Hallen A, Pahlson C, Forsum U. Bacterial vaginosis in women attending STD clinic: diagnostic criteria and prevalence of Mobiluncus spp. Genitourin Med. 1987;63(6):386-389. (Pubitemid 18026259)
46. Johnson HL, Ghanem KG, Zenilman JM, Erbelding EJ. Sexually transmitted infections and adverse pregnancy outcomes among women attending inner city public sexually transmitted diseases clinics. Sex Transm Dis. 2011;38(3):167-171.
47. Lamont RF, Morgan DJ, Wilden SD, Taylor-Robinson D. Prevalence of bacterial vaginosis in women attending one of three general practices for routine cervical cytology. Int J STD AIDS. 2000;11(8):495-498. (Pubitemid 30614388)
48. Morris M, Nicoll A, Simms I, Wilson J, Catchpole M. Bacterial vaginosis: a public health review. BJOG. 2001;108(5):439-450. (Pubitemid 32607306)
49. Wawer MJ, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet. 1999;353(9152):525-535. (Pubitemid 29078422)
50. Verhelst R, et al. Comparison between Gram stain and culture for the characterization of vaginal microflora: definition of a distinct grade that resembles grade I microflora and revised categorization of grade I microflora. BMC Microbiol. 2005;5:61.
51. Lopes Dos Santos SG, et al. Gardnerella vaginalis comprises three distinct genotypes of which only two produce sialidase. Am J Obstet Gynecol. 2011; 204(5):450.e1-e7.
52. Brotman RM, Ravel J. Ready or not: the molecular diagnosis of bacterial vaginosis. Clin Infect Dis. 2008;47(1):44-46. (Pubitemid 351920585)
53. Berger BJ, Kolton S, Zenilman JM, Cummings MC, Feldman J, McCormack WM. Bacterial vaginosis in lesbians: a sexually transmitted disease. Clin Infect Dis. 1995;21(6):1402-1405. (Pubitemid 26066629)
54. Marrazzo JM, Koutsky LA, Eschenbach DA, Agnew K, Stine K, Hillier SL. Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis. 2002;185(9):1307-1313. (Pubitemid 34439138)
55. Schwebke JR. Bacterial vaginosis: are we coming full circle? J Infect Dis. 2009;200(11):1633-1635.
56. Schwebke JR, Desmond R. Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases. Sex Transm Dis. 2005;32(11):654-658. (Pubitemid 41682150)
57. Beigi RH, Wiesenfeld HC, Hillier SL, Straw T, Krohn MA. Factors associated with absence of H2O2-producing Lactobacillus among women with bacterial vaginosis. J Infect Dis. 2005;191(6):924-929. (Pubitemid 40349808)
58. Koumans EH, Markowitz LE, Berman SM, St Louis ME. A public health approach to adverse outcomes of pregnancy associated with bacterial vaginosis. Int J Gynaecol Obstet. 1999;67 suppl 1:S29-S33.
59. Ness RB, et al. Can known risk factors explain racial differences in the occurrence of bacterial vaginosis? J Natl Med Assoc. 2003;95(3):201-212. (Pubitemid 37101966)
60. Tchamouroff SE, Panja SK. The association between receptive cunnilingus and bacterial vaginosis. Sex Transm Infect. 2000;76(2):144-145. (Pubitemid 30262262)
61. Brotman RM, Ravel J, Cone RA, Zenilman JM. Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis. Sex Transm Infect. 2010; 86(4):297-302.
62. Schmid GP. The epidemiology of bacterial vaginosis. Int J Gynaecol Obstet. 1999;67 suppl 1:S17-S20.
63. Schwebke JR, Richey CM, Weiss HL. Correlation of behaviors with microbiological changes in vaginal flora. J Infect Dis. 1999;180(5):1632-1636. (Pubitemid 29506468)
64. Vutyavanich T, Pongsuthirak P, Vannareumol P, Ruangsri RA, Luangsook P. A randomized doubleblind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstet Gynecol. 1993;82(4 pt 1):550-554. (Pubitemid 23278256)
65. Mengel MB, et al. The effectiveness of single-dose metronidazole therapy for patients and their partners with bacterial vaginosis. J Fam Pract. 1989; 28(2):163-171. (Pubitemid 19068365)
66. Colli E, Landoni M, Parazzini F. Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourin Med. 1997;73(4):267-270. (Pubitemid 27376689)
67. Swedberg J, Steiner JF, Deiss F, Steiner S, Driggers DA. Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis. JAMA. 1985;254(8):1046-1049. (Pubitemid 15012824)
68. Doderlein A. Das Scheidensekret und seine Bedeutung fur Puerperalfieber (1892). Whitefish, Montana, USA: Kessinger Publishing, LLC; 2010.
69. Verhelst R, et al. Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol. 2004;4:16.
70. Boskey ER, Telsch KM, Whaley KJ, Moench TR, Cone RA. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun. 1999;67(10):5170-5175. (Pubitemid 29455288)
71. Klaenhammer TR. Bacteriocins of lactic acid bacteria. Biochimie. 1988;70(3):337-349.
72. Ocana VS, Pesce De Ruiz Holgado AA, Nader-Macias ME. Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain. Appl Environ Microbiol. 1999; 65(12):5631-5635. (Pubitemid 129520666)
73. ten Brink B, Minekus M, van der Vossen JM, Leer RJ, Huis in't Veld JH. Antimicrobial activity of lactobacilli: preliminary characterization and optimization of production of acidocin B, a novel bacteriocin produced by Lactobacillus acidophilus M46 J Appl Bacteriol. 1994;77(2):140-148. (Pubitemid 24257210)
74. Yudin MH, Landers DV, Meyn L, Hillier SL. Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial. Obstet Gynecol. 2003;102(3):527-534. (Pubitemid 37311216)
75. Owen DH, Katz DF. A vaginal fluid simulant. Contraception. 1999;59(2):91-95. (Pubitemid 29244754)
76. O'Hanlon DE, Moench TR, Harrold S, Cone RA. Microbicide production by vaginal lactobacilli: vaginal acidity (pH) and lactic acid or more potent than previously reported. Poster presentation at: Microbicides Conference; February 24-28, 2008; New Delhi, India.
77. Lai SK, et al. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol. 2009;83(21):11196- 11200.
78. O'Hanlon DE, Moench TR, Cone RA. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect Dis. 2011;11:200.
79. O'Hanlon DE, Lanier BR, Moench TR, Cone RA. Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli. BMC Infect Dis. 2010;10:120.
80. Sobel JD. Bacterial vaginosis. Annu Rev Med. 2000; 51:349-356. (Pubitemid 30216042)
81. Ferris MJ, Norori J, Zozaya-Hinchliffe M, Martin DH. Cultivation- independent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J Clin Microbiol. 2007;45(3):1016-1018. (Pubitemid 46427726)
82. Ghanem KG, Hutton HE, Zenilman JM, Zimba R, Erbelding EJ. Audio computer assisted self interview and face to face interview modes in assessing response bias among STD clinic patients. Sex Transm Infect. 2005;81(5):421-425. (Pubitemid 41494359)
83. Forney LJ, Foster JA, Ledger W. The vaginal flora of healthy women is not always dominated by lactobacillus species. J Infect Dis. 2006;194(10):1468- 1469. (Pubitemid 44706519)
84. Bartlett JG, et al. Quantitative bacteriology of the vaginal flora. J Infect Dis. 1977;136(2):271-277. (Pubitemid 8170993)
85. Hay PE, Ugwumadu A, Chowns J. Sex, thrush and bacterial vaginosis. Int J STD AIDS. 1997;8(10):603-608. (Pubitemid 27389423)
86. Keane FE, Ison CA, Taylor-Robinson D. A longitudinal study of the vaginal flora over a menstrual cycle. Int J STD AIDS. 1997;8(8):489-494. (Pubitemid 27308586)
87. Priestley CJ, Jones BM, Dhar J, Goodwin L. What is normal vaginal flora? Genitourin Med. 1997; 73(1):23-28. (Pubitemid 27076083)
88. Verstraelen H, Verhelst R, Claeys G, De Backer E, Temmerman M, Vaneechoutte M. Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L. iners are more conducive to the occurrence of abnormal vaginal microflora. BMC Microbiol. 2009;9:116.
89. Srinivasan S, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS ONE. 2010;5(4):e10197.
90. McCook A. The vagina catalogues. Nat Med. 2011; 17(7):765-767.
91. Peterson J, et al. The NIH human microbiome project. Genome Res. 2009;19(12):2317-2323.
92. Eschenbach DA, et al. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis. 2000;30(6):901-907. (Pubitemid 32250327)
93. Brotman RM, et al. A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis. Am J Epidemiol. 2008; 168(2):188-196. (Pubitemid 351951592)
94. Neggers YH, et al. Dietary intake of selected nutrients affects bacterial vaginosis in women. J Nutr. 2007; 137(9):2128-2133. (Pubitemid 47367276)
95. Mercer BM, Taylor MC, Fricke JL, Baselski VS, Sibai BM. The accuracy and patient preference for self-collected group B Streptococcus cultures. Am J Obstet Gynecol. 1995;173(4):1325-1328.
96. Kim TK, et al. Heterogeneity of vaginal microbial communities within individuals. J Clin Microbiol. 2009;47(4):1181-1189.
97. Nelson DB, Bellamy S, Gray TS, Nachamkin I. Self-collected versus provider-collected vaginal swabs for the diagnosis of bacterial vaginosis: an assessment of validity and reliability. J Clin Epidemiol. 2003;56(9):862-866. (Pubitemid 37162660)
98. Forney LJ, et al. Comparison of self-collected and physician-collected vaginal swabs for microbiome analysis. J Clin Microbiol. 2010;48(5):1741-1748.
99. Menard JP, Fenollar F, Raoult D, Boubli L, Bretelle F. Self-collected vaginal swabs for the quantitative real-time polymerase chain reaction assay of Atopobium vaginae and Gardnerella vaginalis and the diagnosis of bacterial vaginosis [published online ahead of print July 26, 2011]. Eur J Clin Microbiol Infect Dis. doi:10.1007/s10096-011-1341-8.
100. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992;19(2):61-77. (Pubitemid 23101885)
101. Grosskurth H, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995;346(8974):530-536.
102. Laga M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS. 1993; 7(1):95-102. (Pubitemid 23069039)
103. Peipert JF, Lapane KL, Allsworth JE, Redding CA, Blume JD, Stein MD. Bacterial vaginosis, race, and sexually transmitted infections: does race modify the association? Sex Transm Dis. 2008;35(4):363-367. (Pubitemid 351440778)
104. Brotman RM, et al. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis. 2010; 202(12):1907-1915.
105. Ness RB, Kip KE, Soper DE, Stamm CA, Rice P, Richter HE. Variability of bacterial vaginosis over 6- to 12-month intervals. Sex Transm Dis. 2006; 33(6):381-385. (Pubitemid 43833026)
106. McGrory T, Meysick K, Lemchuk-Favel LT, Garber GE. The interaction of Lactobacillus acidophilus and Trichomonas vaginalis in vitro. J Parasitol. 1994; 80(1):50-54. (Pubitemid 24058883)
107. Schwebke JR, Desmond R. A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol. 2007;196(6):517.
108. National Institute of Allergy and Infectious Diseases (NIAID). Bacterial vaginosis home screening to prevent STDs. NIH web site. http://clinicaltrials. gov/ct2/show/NCT00667368. Accessed September 19, 2011.
109. Spear GT, Sikaroodi M, Zariffard MR, Landay AL, French AL, Gillevet PM. Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis. J Infect Dis. 2008;198(8):1131-1140.
110. Brotman RM, et al. 2011. Association between Trichomonas vaginalis and the vaginal microbiota among asymptomatic reproductive-age women in the United States: A cross-sectional study. Paper presented at: 19th Biennial Congress of the International Society for Sexually Transmitted Disease Research; July 11-13, 2011; Quebec City, Quebec, Canada.
111. Hillier SL. The vaginal microbial ecosystem and resistance to HIV. AIDS Res Hum Retroviruses. 1998; 14 suppl 1:S17-S21. (Pubitemid 28208884)
112. Redondo-Lopez V, Cook RL, Sobel JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis. 1990;12(5):856-872. (Pubitemid 20349968)